1. Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis. (March 2018) Authors: Nguyen, V.; Brauneis, D.; Kaku, M.; Sloan, J.; Sarosiek, S.; Quillen, K.; Shelton, A.; Sanchorawala, V. Journal: Bone marrow transplantation Issue: Volume 53:Number 3(2018) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA. (23rd June 2022) Authors: Zanwar, S.; Abeykoon, J.; Castillo, J.; Durot, E.; Kastritis, E.; Uppal, E.; Morel, P.; Tawfiq, R.; Montes, L.; Paludo, J.; Sarosiek, S.; Kumar, S.; Ogunbiyi, O.; Cornillet-Lefebvre, P.; Kyle, R.; Delmer, A.; Gertz, M.; Dimopoulos, M.; Ansell, S.; Treon, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1046 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗